Survival in uremia due to systemic diseases.
A retrospective analysis of the mortality and morbidity experience with maintenance hemodialysis as treatment for uremia in systemic disease was conducted. Between 1962 and 1977, a total of 141 patients with chronic glomerulonephritis and 120 patients with uremia caused by renal involvement in systemic disease were treated. With the exception of two patients with bacterial endocarditis who died early in their course, survival in the diagnostic categories studied ranged from acceptable, in diabetics with 29 of 53 (54.7%) patients living, to excellent in tuberculosis where all of six patients are alive and well. Overall, it is concluded that uremia in systemic disease is responsive to maintenace hemodialysis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000686:Amyloidosis / Q000150:complications; D003928:Diabetic Nephropathies / Q000150:complications; D004696:Endocarditis / Q000150:complications; D005260:Female; D005921:Glomerulonephritis / Q000150:complications; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications; D009518:New York; D006435:Renal Dialysis; D012189:Retrospective Studies; D012805:Sickle Cell Trait / Q000150:complications; D014376:Tuberculosis / Q000150:complications; D014511:Uremia / Q000209:etiology / Q000401:mortality* / Q000628:therapy